SC 13G/A | 2024-02-14 | BAKER BROS. ADVISORS LP | BIOCRYST PHARMACEUTICALS INC | 10,126,176 | 4.9% | EDGAR |
SC 13G | 2024-02-14 | Avoro Capital Advisors LLC | BIOCRYST PHARMACEUTICALS INC | 13,050,000 | 6.4% | EDGAR |
SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | BIOCRYST PHARMACEUTICALS INC | 17,763,720 | 8.7% | EDGAR |
SC 13G/A | 2024-01-24 | STATE STREET CORP | BIOCRYST PHARMACEUTICALS INC | - | 6.2% | EDGAR |
SC 13G/A | 2024-01-24 | BlackRock Inc. | BIOCRYST PHARMACEUTICALS INC | 18,681,370 | 9.1% | EDGAR |
SC 13G/A | 2023-02-14 | BAKER BROS. ADVISORS LP | BIOCRYST PHARMACEUTICALS INC | 19,106,881 | 9.9% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | BIOCRYST PHARMACEUTICALS INC | 14,204,395 | 7.6% | EDGAR |
SC 13G/A | 2023-02-06 | STATE STREET CORP | BIOCRYST PHARMACEUTICALS INC | - | 6.0% | EDGAR |
SC 13G/A | 2023-02-03 | BlackRock Inc. | BIOCRYST PHARMACEUTICALS INC | 14,918,955 | 8.0% | EDGAR |
SC 13G/A | 2022-02-14 | BAKER BROS. ADVISORS LP | BIOCRYST PHARMACEUTICALS INC | 18,386,831 | 9.9% | EDGAR |
SC 13G/A | 2022-02-09 | STATE STREET CORP | BIOCRYST PHARMACEUTICALS INC | - | 4.6% | EDGAR |
SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | BIOCRYST PHARMACEUTICALS INC | 9,412,905 | 5.2% | EDGAR |
SC 13G/A | 2022-02-01 | BlackRock Inc. | BIOCRYST PHARMACEUTICALS INC | 14,787,395 | 8.2% | EDGAR |
SC 13G/A | 2021-04-12 | STATE STREET CORP | BIOCRYST PHARMACEUTICALS INC | - | 4.1% | EDGAR |
SC 13G/A | 2021-02-16 | Point72 Asset Management, L.P. | BIOCRYST PHARMACEUTICALS INC | 3,230,800 | 1.8% | EDGAR |
SC 13G/A | 2021-02-16 | CITADEL ADVISORS LLC | BIOCRYST PHARMACEUTICALS INC | - | 3.5% | EDGAR |
SC 13G/A | 2021-02-16 | BAKER BROS. ADVISORS LP | BIOCRYST PHARMACEUTICALS INC | 18,100,968 | 10.0% | EDGAR |
SC 13G/A | 2021-02-11 | JANUS HENDERSON GROUP PLC | BIOCRYST PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | BIOCRYST PHARMACEUTICALS INC | 11,599,334 | 6.6% | EDGAR |
SC 13G/A | 2021-02-10 | INTEGRATED CORE STRATEGIES (US) LLC | BIOCRYST PHARMACEUTICALS INC | 31,130 | 0.0% | EDGAR |